inspection – Page 232

Compression force drift during high-speed compression – CAPA failure explained

Understanding and Addressing Compression Force Drift in High-Speed Tablet Compression Compression force drift during high-speed compression is a critical issue that can compromise product quality and regulatory compliance in pharmaceutical…

Punch tip damage during high-speed compression – FDA inspection observation risk

Punch Tip Integrity Issues During High-Speed Tablet Compression: An Inspection Risk In high-speed tablet production, punch tip damage is a recurring problem that can compromise tablet integrity and ultimately lead…

Turret speed instability during inspection prep – FDA inspection observation risk

Addressing Turret Speed Instability During Inspection Preparation: Strategies for Compliance and Prevention In the fast-paced environment of pharmaceutical manufacturing, equipment failures can lead to significant downtime, regulatory scrutiny, and potential…

Tablet weight variation during inspection prep – FDA inspection observation risk

Addressing Tablet Weight Variation During Inspection Preparation: Strategies for Success In pharmaceutical manufacturing, maintaining consistent tablet weight during inspection prep is not just a quality issue; it’s also a regulatory…

Personnel not trained on revised SOP during deviation investigation – QMS remediation failure

Case Study: Addressing Training Gaps in SOP Compliance During Deviation Investigations In the complex environment of pharmaceutical manufacturing, the risk of compliance failures can often stem from seemingly minor lapses…

Media fill deviation not escalated during cleaning verification – containment CAPA failure

“`html Case Study on Unmanaged Media Fill Deviation During Cleaning Verification The pharmaceutical manufacturing industry is highly regulated, where even minor deviations can have significant consequences on product quality and…

Personnel not trained on revised SOP during audit – QMS remediation failure

Case Study: Addressing Personnel Training Gaps on Revised SOPs During Audit In the highly regulated pharmaceutical industry, adherence to standard operating procedures (SOPs) is critical for maintaining quality and compliance.…

Document revisions uncontrolled during deviation investigation – QMS remediation failure

Uncontrolled Document Revisions During a Deviation Investigation: A Quality Management System Remediation Case Study In the high-stakes world of pharmaceutical manufacturing, the integrity of documentation is non-negotiable. This case study…

GDP errors repeated during audit – inspection citation risk explained

Understanding and Managing Repeated GDP Errors During Regulatory Audits In the highly regulated pharmaceutical environment, the accuracy and integrity of Good Distribution Practice (GDP) are crucial for maintaining compliance with…

Training effectiveness not assessed during audit – inspection citation risk explained

Understanding Inspection Risks Due to Unassessed Training Effectiveness In a typical pharmaceutical manufacturing environment, the compliance with Good Manufacturing Practices (GMP) goes beyond just adhering to technical standards. During a…

Backdated training evidence during audit – inspection citation risk explained

Understanding Risks of Backdated Training Evidence in Pharmaceutical Audits In the realm of pharmaceutical manufacturing and quality assurance, the credibility of training documentation is critical. An incident involving backdated training…

Personnel not trained on revised SOP during inspection – QMS remediation failure

Case Study: Addressing Personnel Training Gaps During Regulatory Inspections In the pharmaceutical industry, adherence to Standard Operating Procedures (SOPs) is not just a regulatory requirement but a critical component of…